InVitria has expanded its manufacturing capacity to meet commercial demands for Lysobac. Lysobac is an animal free reagent for bacterial fermentation.
InVitria claims, Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation.
Manufactured in an animal free production system, InVitria’s Lysobac is a cost-effective, more consistent and performance enhancing alternative to chicken lysozyme, also called hen egg white lysozyme (HEWL), said the company.
Greg Unruh, vice president of production at InVitria, said: “With the increase in production capacity at our ISO 9001 facility, we now have the ability to supply large volumes of Lysobac to commercial customers all over the world.”
Scott Deeter, president and CEO of InVitria, said: “InVitria customers have achieved significant performance and safety benefits from using Lysobac as a cell lysis reagent. Further, Lysobac allows manufacturers to switch to an animal free production system and avoid the risk of contaminants from animal derived components.”